Asia Pac ECM and Index Rebal, DZT Research

Ke Yan, CFA, FRM

An inquisitive investment analyst with background in both finance and computing. Covering ECM research, biotech, market data analytics.

Asia Pac ECM and Index Rebal

SELL Pop Mart (9992 HK): Takeaways from Post-Results Briefing

SELL Pop Mart (9992 HK): Mild Revision, Shorts Rebuilt, Trapped Southbound Money

SELL Pop Mart (9992 HK): Seasonal Trough, Not Structural Trough; August Is the Test

SELL Pop Mart (9992 HK): Pre-Earning Update

Sell Pop Mart (9992 HK) Updates (2026 Jan): Offline Channel Checks and Trend Data

2026 High Conviction: Sell Pop Mart Intl (9992 HK)

Asia Pac IPO & Placement Research, China Biotech

DZT Research

DZT Research is an independent Asia Pacific equity specialist. Our quantitative research covers index rebalancing flows, alongside exchange data analytics accross Asia Pacific. On the equity capital markets side, we focus on Asia Pacific ECM, especially biotech and TMT. Our lead analyst is frequently cited by international media.

Equity Bottom-Up

<ul>
<li>Pop Mart Intl (9992 HK) just announced FY2025 results after the morning trading session.</li>
<li>The reported top line inline with consensus with margin beats.</li>
<li>Our analysis shows concerns over growth and Labubu dependency towards late 2025.</li>
</ul>


Pop Mart Intl (9992 HK) just announced FY2025 results after the morning trading session.
The reported top line inline with consensus with margin beats.
Our analysis shows concerns over growth and Labubu dependency towards late 2025.


ポップマート（9992 HK）の売却：結果速報